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with a soft pancreas and non-dilated duct
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Abstract
Background. We performed duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa in 55 patients, and here
compare the clinical results between duct-to-mucosa pancreaticojejunostomies with a non-dilated pancreatic duct and those
with a dilated duct. Patients and methods. In the period 1999 to 2005, 55 patients (27 F, 28 M; mean age 63.4 years)
underwent duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa. A non-dilated pancreatic duct was
observe in 29 patients in group A and a dilated pancreatic duct in 26 patients in group B. Clinical characteristics (age,
gender, benign or malignant condition, presence of diabetes mellitus, anastomotic time) were analyzed in both groups and
postoperative complications were compared between groups. Results. In a comparison of clinical characteristics, all factors
were similar between groups. In group A, the postoperative complication occurred in 4 (wound infection in 2, pulmonary
embolism in 1, gastric ulcer in 1) of 29 patients (13.8%), and in group B in 1 (pneumothorax) of 26 patients (3.8%). No
pancreatic leakage was observed in either group. The difference between group A and group B in the rate of postoperative
complication was not statistically significant. Conclusions. There was no statistical difference in the rate of postoperative
complications, including pancreatic leakage, between duct-to-mucosa pancreaticojejunostomies with a dilated pancreatic
duct and those with a non-dilated duct. We consider that the diameter of the pancreatic duct is irrelevant to results of duct-
to-mucosa pancreaticojejunostomy.
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Introduction
Pancreaticoduodenectomy is the standard surgical
procedure for resecting pancreatic and periampullary
neoplasms. Thanks to technical improvements in
recent years, the mortality rate of pancreaticoduode-
nectomy has dropped below 5% [13]. However,
pancreatic anastomotic leakage after pancreaticoduo-
denectomy remains a major troublesome complica-
tion. Pancreatic leakage often results in significant
morbidity and mortality. Moreover, it is widely
accepted that pancreatic anastomotic leakage is
more likely to occur in a patient with a soft pancreas
and non-dilated pancreatic duct than in a patient with
a hard pancreas and a dilated duct. In this study, we
compare between the clinical results of duct-to-
mucosa pancreaticojejunostomy with a non-dilated
pancreatic duct and duct-to-mucosa pancreaticojeju-
nostomy with a dilated duct.
Patients and methods
In the period January 1999 to December 2005, 55
patients underwent duct-to-mucosa pancreaticojeju-
nostomy (27 F and 28 M; mean age 63.4 years
(63.4910.4, range 3380)). A non-dilated pancreatic
duct was seen in 29 patients in group A and a dilated
pancreatic duct in 26 patients in group B. The
diseases in groups A and B are indicated in Table I
and the surgical procedures of both groups in Table II.
Postoperative complications were compared between
groups and clinical characteristics (age, gender, be-
nign, or malignant condition, presence of diabetes
mellitus, anastomotic time) were analyzed. Diagnosis
of the pancreatic leakage was defined from the
following findings: the level of amylase in the dis-
charge fluid more than three times the serum level of
amylase on the 7th day after operation, or the level of
amylase more than 1000 IU/l on the 7th day after
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surgery. All procedures were performed by the same
surgeon using the same technique, same approach
and same anastomotic fashion in order to avoid
technical bias.
Surgical procedure of duct-to-mucosa
pancreaticojejunostomy
The pancreas was sharply transected with a scalpel on
a schedule line in pancreaticoduodenectomy. The
jejunal serosa was resected a little smaller than the
size of the pancreatic stump, and mucosa of jejunum
was exposed at the anastomotic point (Figure 1).
Serosa resection was thought to promote vasculariza-
tion and enhance the anastomotic healing process [4].
The dorsal parts of the jejunal seromuscular layer and
of the pancreatic capsular parenchyma of the stump
were sutured to leave no dead space. Anastomosis
between pancreatic duct and jejunal mucosa was then
carried out (Figure 2) and a stent tube was inserted
into the main pancreatic duct for luminal decompres-
sion. The ventral part of both the jejunal seromus-
cular layer and the pancreatic capsular parenchyma of
the stump was sutured (Figure 3).
Statistical analysis
Continuous variables were reported as the mean9
standard deviation and compared using the Mann-
Whitney U-test. Categorical variables were compared
using the Fisher test. A two-sided p-value B0.05 was
considered statistically significant.
Results
When comparing clinical characteristics (age, gender,
benign or malignant condition, presence of dia-
betes mellitus, anastomotic time), no difference was
observed statistically between groups A and B (Table
III). In group A, the postoperative wound infection
occurred in 2 of 29 patients (6.9%), the postoperative
gastric ulcer with bleeding in 1 of 29 patients (3.4%),
and the postoperative pulmonary embolism in 1 of 29
patients (3.4%). In group B, the postoperative pneu-
mothorax was observed in 1 of 26 patients. Moreover,
pancreatic anastomotic leakage, which was the most
common complication for pancreatic head resection,
Table I. Disease of the patients who underwent duct-to-mucosa pancreaticojejunostomy.
P-duct dilation (]3 mm)
Disease (n26) (n29)
Carcinoma of the pancreas head 21 0
Carcinoma of the Vater papilla 0 7
Carcinoma of the lower bile duct 0 6
Carcinoma of the duodenum 0 5
Carcinoma of the gallbladder 0 3
Intraductal papillary mucinous adenocarcinoma of the pancreas head 2 0
Intraductal papillary mucinous adenoma of the pancreas head 2 2
Tumor-forming pancreatitis 1 1
Carcinoma of the stomach 0 1
Carcinoma of the ascending colon 0 1
Islet cell tumor of the pancreas head 0 1
Duodenal GIST (gastrointestinal stromal tumor) 0 1
Serous cyst adenoma 0 1
Table II. Operative procedure of the patients (n55).
P-duct dilation
(n26) (n29)
PD 8 6
SSPPD 12 10
PPPD 4 8
DPPHR 1 4
PHRSD 0 1
SP 1 0
PDPancreaticoduodenectomy, PPPDpylorus preserving pan-
creaticoduodenectomy, SSPPDsubtotal stomach preserving pan-
creaticoduodenectomy, DPPHR duodenum preserving pancreas
head resection, PHRSDpancreas head resection with second
portion duodenectomy, SPsegmental pancreatectomy. Figure 1. The jejunal serosa was resected st the anastomotic point.
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was not observed in either group. There was no
statistical difference in the rate of postoperative
complications between groups A and B (Table IV).
Discussion
Pancreaticoduodenectomy has become increasingly
safe as a result of continuous technical improvement
over the years. However, pancreatic anastomotic
leakage remains a major troublesome complication
of pancreaticoduodenectomy. The incidence of pan-
creatic leakage has been reported as ranging between
6% and 24%. Pancreatic anastomotic leakage, with
subsequent intra-abdominal abscess, bleeding, and
sepsis, remains the major factor of death and compli-
cations [510]. It has been accepted that a soft
pancreas and a non-dilated pancreatic duct make
pancreatic anastomosis difficult to perform. Yeo
et al. reported that there is a strong association
between pancreatic texture and pancreatic leakage
[11]. In reviewing 161 patients who underwent
pancreaticoduodenectomy, Hosotani et al. reported
a pancreatic fistula rate of 11% (17/161), recognizing
that the pancreatic anastomotic technique, pancreatic
texture, and pancreatic duct size were risk factors for
pancreatic leakage after pancreaticoduodenectomy
[12].
Tani et al. reported that soft pancreas was a higher
risk factor than hard pancreas [13], and Mercuc et al.
that male sex was a significant factor predisposing
pancreatic leakage [14]. In the study by Yeh et al.,
jaundice, creatinine clearance abnormality, and intra-
operative blood loss were identified as significant risk
factors for pancreatic leakage [15]. Matsusue et al.
reported that advanced age (over 70 years) was an
adverse factor for leakage [16]. Based on the accu-
mulated evidence so far, conclusion might not be
easily drawn to estimate a risk factor for pancreatic
leakage, since the anastomotic leakage rate is highly
related to the operative technique and experience of
the surgeon. In this study, a comparison between
duct-to-mucosa pancreaticojejunostomies with a soft
pancreas and a non-dilated pancreatic duct and duct-
to-mucosa pancreaticojejunostomies with a hard pan-
creas and a dilated duct was performed with respect to
anastomotic leakage and other postoperative compli-
cations. As for the results of pancreatic anastomotic
Figure 3. Silicon tube for decompression of pancreatic juice and the
completion of the duct-to-mucosa anastomosis.
Figure 2. The anastomosis between the posterior wall of the
pancreatic duct and the jejunal mucosa was done.
Table III. Comparison of demographics and clinical characteristics in patients with a dilated P-duct and patients with a non-dilated duct.
Patients with a dilated P-duct Patients with a non-dilated duct
(n26) (n29) p-value
Age (years) 63.796.9 64.5912.4 0.8
Gender (M/F) 13/13 15/14 0.9
Benign/malignant 3/23 4/25 0.8
DM (yes/no) 5/21 7/22 0.7
Anastomotic time (mm) 21.094.2 23.796.3 0.2
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leakage, no differences were observed between either
group. Regardless of the diameter of the pancreatic
duct, duct-to-mucosa pancreaticojejunostomy was
recommended since maturation of the surgical tech-
nique decreases the risk of pancreatic anastomotic
leakage.
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Table IV. Comparison of complications in patients with a dilated P-duct and patients with a non-dilated duct.
Patients with
P-duct dilatation
Patients with
P-duct non-dilatation p-value
Wound infection 0 2
Pneumothorax 1 0
Gastric ulcer with bleeding 0 1
Pulmonary embolism 0 1
Pancreatic leakage 0 0
Total 1 (/26) 4 (/29) 0.2
Pancreatic leakage: the level of amylase in the discharge fluid more than 1000 IU/l on 7th day after surgery.
Duct-to-mucosa pancreaticojejunostomy 57
